Outcome of isolated congenital complete heart block diagnosed in utero.

A. M. Groves, L. D. Allan, E. Rosenthal

Department of Fetal Cardiology, Guy's Hospital, London.

OBJECTIVE: To establish identifiable prenatal factors in fetal heart block which might predict death in utero, the need for intervention, or the probability of pacemaker requirement. SETTING: Tertiary referral unit for fetal echocardiography. SUBJECTS: 36 fetuses with congenital complete heart block and structurally normal hearts identified between 1980 and 1993. METHODS: Maternal anti-Ro antibody status was documented. Prenatal variables examined included absolute heart (ventricular) rate, change in rate, and development of hydrops fetalis. Postnatally, heart rate, need for pacing, and the indications for pacing were detailed. RESULTS: Of the total of 36 patients, there are 24 survivors; 11 are paced. Of those fetuses which died, two were electively aborted for severe hydrops, seven died in utero, two were immediate postnatal deaths, and one was an unrelated infant death. The trend was for the heart rate to decrease during fetal life and postnatally. Fetuses with deteriorating cardiac function did not always show the lowest heart rates. Bradycardia of less than 55 beats/min in early pregnancy or rapid decrease in heart rate prenatally were poor prognostic signs. Hydrops was also associated with bad outcome, 10 out of the 12 hydropic fetuses dying (83%). Of 10 fetuses presenting with a heart rate above 60/min, nine survived of whom three required pacing. Of seven presenting with heart rates of 50/min or less, only three survived and two of these required pacing. Of the two fetuses with negative maternal anti-Ro antibody status one died in utero and one required heart transplantation after pacemaker insertion. CONCLUSIONS: Isolated complete heart block identified in fetal life does not always have a good prognosis. An individual heart rate does not accurately predict the outcome in utero or the need for postnatal pacing. Regular, careful monitoring during pregnancy is required in order to optimise care and timing of any interventions.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Relevant Article

Outcome of isolated congenital heart block diagnosed in utero.

L. G. Guereta, M. Burgueros, and F. Moreno
Heart 1997 78: 95-96. [PDF]

This article has been cited by other articles:

• BRUCATO, A., GRAVA, C., BORTOLATI, M., IKEDA, K., MILANESI, O., CIMAZ, R., RAMONI, V., VIGNATI, G., MARTINELLI, S., SADOU, Y., BORGHI, A., TINCANI, A., CHAN, E. K.L., RUFFATTI, A. (2009). Congenital Heart Block Not Associated with Anti-Ro/La Antibodies: Comparison with Anti-Ro/La-positive Cases. The Journal of Rheumatology 36: 1744-1748 [Abstract] [Full Text]  
• Lopes, L. M., Tavares, G. M. P., Damiano, A. P., Lopes, M. A. B., Aiello, V. D., Schultz, R., Zugaib, M. (2008). Perinatal Outcome of Fetal Atrioventricular Block: One-Hundred-Sixteen Cases From a Single Institution. Circulation 118: 1268-1275 [Abstract] [Full Text]  
• Glatz, A. C., Gaynor, J. W., Rhodes, L. A., Rychik, J., Tanel, R. E., Vetter, V. L., Kaltman, J. R., Nicolson, S. C., Montenegro, L., Shah, M. J. (2008). Outcome of high-risk neonates with congenital complete heart block paced in the first 24 hours after birth. J. Thorac. Cardiovasc. Surg. 136: 767-773 [Abstract] [Full Text]  
• Killen, S. A.S., Fish, F. A. (2008). Fetal and Neonatal Arrhythmias. NeoReviews 9: e242-e252 [Abstract] [Full Text]  
• Skog, A., Wahren-Herlenius, M., Sundstrom, B., Bremme, K., Sonesson, S.-E. (2008). Outcome and Growth of Infants Fetally Exposed to Heart Block-Associated Maternal Anti-Ro52/SSA Autoantibodies. Pediatrics 121: e803-e809 [Abstract] [Full Text]  
• Hornberger, L. K., Collins, K. (2008). New insights into fetal atrioventricular block using fetal magnetocardiography.. J Am Coll Cardiol 51: 85-86 [Full Text]  
• Gardiner, H. M, Belmar, C., Pasquini, L., Seale, A., Thomas, M., Dennes, W., Taylor, M. J O, Kulinskaya, E., Wimalasundera, R. (2007). Fetal ECG: a novel predictor of atrioventricular block in anti-Ro positive pregnancies. Heart 93: 1454-1460 [Abstract] [Full Text]  
• Gordon, P.A. (2007). Review: Congenital heart block: clinical features and therapeutic approaches. Lupus 16: 642-646 [Abstract]  
• Khositseth, A., Samankatiwat, P., Withurawanit, W., Khowsathit, P. (2006). Pacing in Preterm with Hydrops Fetalis due to Congenital Complete Heart Block. Asian Cardiovasc. Thorac. Ann. 14: 428-431 [Abstract] [Full Text]  
• Maeno, Y, Himeno, W, Saito, A, Hiraishi, S, Hirose, O, Ikuma, M, Inamura, N, Kawataki, M, Mizukami, A, Ota, M, Shiraishi, H, Satomi, G, Kato, H (2005). Clinical course of fetal congenital atrioventricular block in the Japanese population: a multicentre experience. Heart 91: 1075-1079 [Abstract] [Full Text]  
• Salomonsson, S., Sonesson, S.-E., Ottosson, L., Muhallab, S., Olsson, T., Sunnerhagen, M., Kuchroo, V. K., Thoren, P., Herlenius, E., Wahren-Herlenius, M. (2005). Ro/SSA autoantibodies directly bind cardiomyocytes, disturb calcium homeostasis, and mediate congenital heart block. JEM 201: 11-17 [Abstract] [Full Text]  
• Thambo, J.-B., Bordachar, P., Garrigue, S., Lafitte, S., Sanders, P., Reuter, S., Girardot, R., Crepin, D., Reant, P., Roudaut, R., Jais, P., Haissaguerre, M., Clementy, J., Jimenez, M. (2004). Detrimental Ventricular Remodeling in Patients With Congenital Complete Heart Block and Chronic Right Ventricular Apical Pacing. Circulation 110: 3766-3772 [Abstract] [Full Text]  
• Jaeggi, E. T., Fouron, J.-C., Silverman, E. D., Ryan, G., Smallhorn, J., Hornberger, L. K. (2004). Transplacental Fetal Treatment Improves the Outcome of Prenatally Diagnosed Complete Atrioventricular Block Without Structural Heart Disease. Circulation 110: 1542-1548 [Abstract] [Full Text]  
• Rosenthal, E (2003). Classification of congenital complete heart block: autoantibody-associated or isolated?. Lupus 12: 425-426  
• Brucato, A, Jonzon, A, Friedman, D, Allan, L D, Vignati, G, Gasparini, M, Stein, J I, Montella, S, Michaelsson, M, Buyon, J (2003). Proposal for a new definition of congenital complete atrioventricular block. Lupus 12: 427-435 [Abstract]  
• Jaeggi, E. T., Hamilton, R. M., Silverman, E. D., Zamora, S. A., Hornberger, L. K. (2002). Outcome of children with fetal, neonatal or childhood diagnosis of isolated congenital atrioventricular block: A single institution's experience of 30 years. J Am Coll Cardiol 39: 130-137 [Abstract] [Full Text]  
• Balmer, C., Fasnacht, M., Rahn, M., Molinari, L., Bauersfeld, U. (2002). Long-term follow up of children with congenital complete atrioventricular block and the impact of pacemaker therapy. Europace 4: 345-349 [Abstract]  
• Gardiner, H M (2001). Fetal echocardiography: 20 years of progress. Heart 86: ii12-22 [Full Text]  
• Moak, J. P., Barron, K. S., Hougen, T. J., Wiles, H. B., Balaji, S., Sreeram, N., Cohen, M. H., Nordenberg, A., Van Hare, G. F., Friedman, R. A., Perez, M., Cecchin, F., Schneider, D. S., Nehgme, R. A., Buyon, J. P. (2001). Congenital heart block: development of late-onset cardiomyopathy, a previously underappreciated sequela. J Am Coll Cardiol 37: 238-242 [Abstract] [Full Text]  
• Eronen, M., Sirèn, M.-K., Ekblad, H., Tikanoja, T., Julkunen, H., Paavilainen, T. (2000). Short- and Long-Term Outcome of Children With Congenital Complete Heart Block Diagnosed In Utero or as a Newborn. Pediatrics 106: 86-91 [Abstract] [Full Text]  
• Rosenthal, E (1998). New insights into the pathogenesis of anti-Ro antibody associated congenital complete heart block. Lupus 7: 135-136